Thu, October 5, 2023
Wed, October 4, 2023
Tue, October 3, 2023
Mon, October 2, 2023
Sun, October 1, 2023
Fri, September 29, 2023

Joel Beatty Maintained (SNDX) at Buy with Decreased Target to $28 on, Oct 3rd, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-28-on-oct-3rd-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Joel Beatty of Baird, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Buy with Decreased Target from $32 to $28 on, Oct 3rd, 2023.

Joel has made no other calls on SNDX in the last 4 months.



There are 8 other peers that have a rating on SNDX. Out of the 8 peers that are also analyzing SNDX, 0 agree with Joel's Rating of Hold.



These are the ratings of the 8 analyists that currently disagree with Joel


  • Edward White of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $42 on, Monday, October 2nd, 2023
  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $33 on, Wednesday, August 16th, 2023
  • George Farmer of "Scotiabank" Initiated at Buy and Held Target at $39 on, Thursday, July 27th, 2023
  • Peter Lawson of "Barclays" Maintained at Buy with Increased Target to $34 on, Wednesday, July 26th, 2023
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $35 on, Wednesday, July 26th, 2023
  • Kalpit Patel of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $36 on, Tuesday, July 25th, 2023
  • Michael Schmidt of "Guggenheim" Maintained at Strong Buy with Increased Target to $42 on, Tuesday, July 25th, 2023
  • Justin Zelin of "BTIG" Maintained at Strong Buy with Increased Target to $35 on, Monday, June 26th, 2023

Publication Contributing Sources